Confirmed speakers for the Health Leaders Research Congress 2018 include:

Prof. Jan-Ingvar Jönsson

Chair of Joint Committee of the Nordic Medical Research Councils, Secretary General, Medicine and Health, Swedish Research Council

Ed Whiting

Director of Policy and Chief of Staff, Wellcome Trust

Ed Whiting has worked in a number of Whitehall social and financial policy Departments in his civil service career, including in HM Treasury’s financial stability team through the 2008-09 financial crisis. Ed was most recently at No10 Downing Street where he was Deputy Principal Private Secretary to the Prime Minister, leading on public services. In addition to his civil service career, in 2011-12 Ed set up and ran a small arts crowdfunding website, and in 2012-13 was an elected member of the RSA’s Fellowship Council. Ed was awarded an OBE for public service and services to No10 Downing St in the June 2016 Queen’s Birthday Honours list.

Elke Anklam

Director of the Health, Consumers and Reference Materials Directorate, European Commission's Joint Research Centre

Elke Anklam is a chemist by education with specialisation in food, organic and radiation chemistry.

After having obtained her PhD from the University of Hamburg, Germany, she worked in various European research institutions and was teaching as Professor in the Applied University of Fulda, Germany. Since 1991 she has been working in the European Commission’s Joint Research Centre. Between 2006-2012 she was Director of the Institute for Health and Consumer Protection (JRC-IHCP) in Ispra, Italy. From 2013 – June 2016, Elke Anklam was Director of the JRC’s Institute for Reference Materials and Measurements (JRC-IRMM) in Geel, Belgium.

Following an organisational re-structuring of the JRC in July 2016, she became the Director of the Health, Consumers and Reference Materials Directorate in Geel, Belgium and Ispra, Italy. The Directorate covers activities on risk assessment methodologies, alternative to animal testing methods, public health issues (cancer registries and nutrition), food and feed safety and quality, food fraud, nanotechnologies, medical devices and reference materials.

Tom Wang, Ph.D.

Chief International Officer, American Association for the Advancement of Science (AAAS)

Tom Wang is the Chief International Officer of the American Association for the Advancement of Science (AAAS). He also serves as the Director of the AAAS Center for Science Diplomacy. He is responsible for guiding the association’s international engagement strategy and building its international relationships. He co-founded the Center for Science Diplomacy and its open-access policy journal, Science & Diplomacy.

Prior to AAAS, he was a science and technology policy adviser and AAAS Diplomacy Fellow in the U.S. Department of State’s Bureau of East Asian and Pacific Affairs, where he received a Superior Honor Award for his contributions to the diplomatic strategy for addressing a pandemic influenza threat in East Asia.

Dr. Abdul Ghaffar

Executive Director, Alliance for Health Policy and Systems Research (HPSR), World Health Organisation

Dr. Abdul Ghaffar serves as Executive Director of the Alliance for Health Policy and Systems Research (HPSR), shaping the field through developing and testing innovative models in both research and implementation of programmes for health systems strengthening and enhancing the use of evidence in decision-making. A physician by training with a PhD in International Health from the Johns Hopkins University, Dr. Ghaffar has worked in low and middle income countries over the past 30 years, managing a wide range of research portfolios; designing and evaluating national health systems; and training future generations of health systems researchers and decision makers. He started his career as a public health physician in Pakistan, before moving into several leadership positions, including Assistant Director-General of Policy and Planning, and Dean of the Health Services Academy, a national school of public health. He later served as Regional Advisor for Research in the Eastern Mediterranean office of the WHO. His intellectual contributions through many influential papers and seminal global reports and strategies continue to set standards and guidance in Health Policy and Systems Research.

Hon. Keith Martin

Executive Director, Consortium of Universities for Global Health (CUGH)

Dr. Martin is a physician who, since Sept. 2012, has served as the founding Executive Director of the Consortium of Universities for Global Health (CUGH).

Between 1993-2011, Dr. Martin served as a Member of Parliament in Canada’s House of Commons representing a riding on Vancouver Island. During that time, he held shadow ministerial portfolios in foreign affairs, international development, and health. He also served as Canada’s Parliamentary Secretary for Defense. His main areas of focus are in global health, foreign policy, security, international development, conservation and the environment.

Dr. Martin has been on numerous diplomatic missions to areas in crisis including Sudan, Zimbabwe, Mali, Niger, Sierra Leone, Colombia, and the Middle East. He served as a physician in South Africa on the Mozambique border during that country’s civil war. He has travelled widely in Africa, visiting the continent 28 times. He has had over 170 editorial articles published in major newspapers and has appeared frequently as a political and social commentator on television and radio. From 1997-2000, he created and moderated the nationally syndicated, current affairs television program, Beyond Politics. He is currently a board member of the Jane Goodall Institute and the Global Health Council; an editorial board member for the Annals of Global Health; and an advisor to the International Cancer Expert Corps, McGill University’s Global Health Program, SEED Global Health, and the Global Sepsis Alliance. He is a commissioner on the Lancet Commission on Pollution & Health. Dr. Martin is based in Washington, DC, which is the home of CUGH’s Secretariat.

Michael Makanga

Executive Director, European & Developing Countries Clinical Trials Partnership (EDCTP)

Michael Makanga MD, PhD, FRCP Edin is Executive Director of EDCTP since 2015. He is a clinician-scientist from Uganda with 25 years of experience in medical product development, global health and poverty-related diseases in sub-Saharan Africa. He has served in various scientific and policy advisory boards of international product development organisations.

Annemarie Hou

Director of the Executive Office and Chief of Staff, Joint United Nations Programme on HIV/AIDS (UNAIDS)

Annemarie Hou is Director of the Executive Office and Chief of Staff for the Joint United Nations Programme on HIV/AIDS (UNAIDS).

Most recently, she oversaw the communications and advocacy portfolio at UNAIDS where she was responsible for positioning HIV and development issues in the global landscape.

Prior to joining UNAIDS, Ms Hou worked in the philanthropic field—with a focus on health and children’s issues. She was the Communications Director at Casey Family Programmes, an operating foundation dedicated to child welfare issues started by the founder of UPS.

Ms Hou served as the first Global Health Communications Manager at the Bill & Melinda Gates Foundation and as the family’s spokesperson. An award-winning writer she started her career as a television journalist. She serves on the Alumni Advisory Board of the Bill & Melinda Gates Foundation, the Board of Grassroot Soccer and as an advisor to the Graça Machel Trust.

Pascal Garel

Chief Executive, European Hospital and Healthcare Federation (HOPE)

Pascal Garel is Chief Executive of HOPE (European Hospital and Healthcare Federation). Educated in political science and European law, he became Hospital Manager with the diploma of the French National School of Public Health. Following a twelve-year experience in hospitals, he created the International Department of the French Hospital Federation, worked in French Ministry of Health, and still teaches (Paris Dauphine and National School of Public Health).

Dr. Petra Hintze

Head of the Division of Medicine, German Research Foundation (DFG)

Head of Division Life Sciences 3: Medicine, Deutsche Forschungsgemeinschaft (German Research Foundation, DFG), Bonn, Germany
Dr. Petra Hintze is Head of the Division of Medicine at the DFG’s Department of Scientific Affairs.

She studied Biology at the University of Bonn. After following a research career in the field of cancer research, Petra Hintze joined the DFG in 1995. With over 20 years of experience in science management, Hintze has held a wide range of positions at the DFG. Her main focus always being clinical research, she has developed high quality research programmes in the Life Sciences Division, managed the DFG’s Lake Como Meeting on Cancer Research and co-chaired the DFG’s Senate Commission on Clinical Research from 2007 to 2012.

Dr. Natasha Azzopardi-Muscat

President, European Public Health Association (EUPHA)

MD (Melit), MSc Public Health (Melit), MSc Health Services Management (Lond), PhD (Maastricht), FFPH (UK), DLSHTM (Lond)

Dr Azzopardi Muscat is the President of the European Public Health Association (EUPHA). She currently works as a consultant in public health medicine at the Directorate for Health Information and Research in Malta having previously held various senior positions at the Ministry of Health in Malta, including that of Chief Medical Officer. She is also a Senior Lecturer at the University of Malta where she jointly heads the WHO Collaborating Centre on Health Systems and Policies in Small States. Her main area of research is European Union health policy with a particular interest in small state health systems. She has authored several publications on this topic. Natasha is an associate editor of the European Journal of Public Health and BMC Health Services Research. She is involved in several European research projects and networks.

Prof. Lokesh Joshi

Delegate, Research Policy Working Group, European University Association

Professor Lokesh Joshi is the Vice President for Research at the National University of Ireland, Galway.

Professor Joshi’s personal research focuses on the role of complex sugars in health and diseases. He was recruited to Ireland as the Science Foundation Ireland (SFI) Stokes Professor of Glycosciences. He is the Director of the Glycosciences Research group at the National University of Ireland, Galway and is a co-investigator in CÚRAM, the SFI-funded national medical devices research centre. Previously, Professor Joshi was an Associate Professor in the Department of Bioengineering and Director of the Center for Glycoscience and Technologies in the Biodesign Institute at Arizona State University (ASU). He completed postdoctoral and research associate training at Boyce Thompson Institute and Cornell University and received a PhD from Bath University.

Professor Joshi has published more than one hundred articles and has been an active scientist-entrepreneur. He was co-founder of Arizona Engineered Therapeutics. In Ireland he co-founded a Biotech company, Aquila Bioscience, focusing on healthcare solutions.

Dr Sarala Balachandran

Chief Scientist and Project Director, CSIR-IGIB, Council of Scientific and Industrial Research (CSIR) and Open Source Drug Discovery (OSDD) Project, India

Currently working as Chief Scientist at CSIR-IGIB (Institute of Genomics and Integrative Biology) at the Council of Scientific and Industrial Research (CSIR). Have in-depth and comprehensive expertise on various aspects of drug discovery and development in academic settings and pharmaceutical industry. Other work experience includes the following: Project Director of Open Source Drug Discovery (OSDD), which is in the area of drug discovery and development of neglected diseases (Tuberculosis in particular) to provide ‘Affordable healthcare to all’. Spearheaded the PA-824 regimen in Phase IIb clinical trials for MDR TB in India.

PhD in the area of Organic chemistry. Experience of working in the area of Drug Discovery and Development at CIMAP, CDRI, Ranbaxy Research Laboratory in both CRD and NDDR divisions in Gurgaon, Haryana, Nicholas Piramal (Piramal Research Centre in Mumbai).

Have experience of working in several places outside India: In Europe (Cambridge University, England), Canada (Institute Armand Frappier, Laval) and the USA (Virginia Tech, Blacksburg, US). Other areas of work include oncology, inflammation, metabolic disorders and anti-infectives as exemplified by more than 40 publications and patents in these areas. Have also led collaborative projects with multi-national companies (with GSK, UK at Ranbaxy and with Merck, US at Piramal Life Sciences) and with TB Alliance (Global Alliance for TB) in US at CSIR.

Prof. Pancras Hogendoorn

Chair of the Group of Medical Deans, League of European Research Universities (LERU)

Dr. Richard Hegele

Vice Dean, Research and Innovation, Faculty of Medicine at the University of Toronto

Dr. Richard Hegele was born and raised in Toronto, where he received his MD degree from the University of Toronto in 1984. He completed his internship and residency training in Anatomical Pathology at the University of Toronto and is certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Pathology.

Dr. Hegele subsequently completed a PhD in Experimental Pathology at the University of British Columbia (UBC) under the supervision of Dr. James C. Hogg. From 1992-2004, he was promoted through the academic ranks at UBC, attaining the rank of Professor. Some of his administrative and leadership roles at UBC included: Program Director for the Anatomical and General Pathology Residency Training Programs from 2001-03, Interim Head of the Department of Pathology and Laboratory Medicine from 2003-04 and Department Head from 2005-08.

From January 2009 to December 2015, Dr. Hegele served as Professor and Chair of the Department of Laboratory Medicine and Pathobiology at the University of Toronto. From February 2011 to December 2016, he also served as Chief, Department of Paediatric Laboratory Medicine at The Hospital for Sick Children.

Since January 2016, Dr. Hegele has served as Vice Dean, Research and Innovation in the Faculty of Medicine at the University of Toronto. His research interests include the role of viral infections in pediatric asthma and allergy, pathobiology of inflammatory lung diseases, identification of new targets for therapy and prophylaxis of respiratory syncytial virus infections, and respiratory virus-host interactions.

Dr. Raphaëla Kitson-Pantano

Head of International Health Relations, AXA Global Life

Dr. Raphaëla Kitson-Pantano began her career as Director of the ESOF Headquarters in Strasbourg. Following the successful set up of the European Hub of ESOF, she joined the L’Oreal Foundation where she was in charge of Scientific Programmes including the L’Oréal-UNESCO For Women in Science Awards. Raphaëla joined AXA in 2014 as the AXA Research Fund Life & Health Risks Research Officer and is now Head of International Health Relations at AXA Global Life. In her spare time she is a Science Communication Consultant, Vice-President of Euroscience, a member of the ESOF2018 International Steering Committee and Secretary General of Europ’Attitude.